In a phase 3 study of 2,339 adults, weekly retatrutide injections produced up to 25% average weight loss after 80 weeks and improved knee pain and sleep apnea.
In a phase 3 study of 2,339 adults, weekly retatrutide injections produced up to 25% average weight loss after 80 weeks and improved knee pain and sleep apnea.